The Role of Lipiodol in the Treatment of Hepatocellular Carcinoma (HCC) through Transarterial Chemoembolization (TACE)
نویسندگان
چکیده
BOGDAN VALERIU POPA1#, ANA MAGDALENA BRATU2#, COSTIN AURELIAN MINOIU2*#, CLAUDIU TURCULET1#, DRAGOS ENE1#, GABRIEL CONSTANTINESCU1#, MADALINA ILIE1#, MIHAI POPESCU3#, ELISABETA BADILA1# 1 Clinical Emergency Hospital, 8 Floreasca Rd., 014461, Bucharest, Romania 2 Clinical Hospital “Coltea” Bucharest, 1 I.C. Bratianu Str., 030171, Bucharest, Romania 3 UMF Craiova Emergency Hospital, 54 Matei Millo Str., 200348, Craiova, Romania
منابع مشابه
Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with lipiodol. Studies highlighting the use of TACE with DEBs for the treatment of hepatocellular carcinoma (HCC) have shown similar or better results compared ...
متن کاملTransarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
Transarterial chemoembolization (TACE) is a widely used standard treatment for patients with hepatocellular carcinoma (HCC) who are not suitable candidates for curative treatments. The rationale for TACE is that intra-arterial chemotherapy using lipiodol and chemotherapeutic agents, followed by selective vascular embolization, results in a strong cytotoxic effect as well as ischemia (convention...
متن کاملTransarterial Chemoembolization Using Gelatin Sponges or Microspheres Plus Lipiodol-Doxorubicin versus Doxorubicin-Loaded Beads for the Treatment of Hepatocellular Carcinoma
OBJECTIVE To retrospectively compare treatment of hepatocellular carcinoma (HCC) with transarterial chemoembolization (TACE) using gelatin sponges or microspheres plus lipiodol-doxorubicin vs. doxorubicin-loaded drug-eluting beads (DEB). MATERIALS AND METHODS A total of 158 patients with HCC received TACE from November 2010 to November 2011 were enrolled in this study, including 64 (40.5%) re...
متن کاملSorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study
OBJECTIVE Though synergy of sorafenib and transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) is well discussed in previous reports, association of lipiodol retention by sorafenib addition to TACE with the survival outcomes remain elusive. Therefore, we studied the impact of sorafenib addition to TACE on survival outcomes mediated by lipiodol retention. MATERIALS AND METH...
متن کاملTransarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
UNLABELLED Transarterial chemoembolization (TACE) improves survival in patients with hepatocellular carcinoma (HCC) in whom curative therapies are not suitable. The aim of this study was to assess survival differences in patients with hepatic cirrhosis and unresectable HCC treated by (131)I-lipiodol versus TACE or transarterial embolization (TAE). METHODS A retrospective study was performed o...
متن کامل